CRA International (CRAI) director reports sale of 110 shares under Rule 10b5-1 plan
Rhea-AI Filing Summary
CRA International reported that one of its directors sold 110 shares of common stock on December 11, 2025 in an open-market transaction. The shares were disposed of at a price of $198.12 per share, coded as a sale transaction. Following this trade, the director directly beneficially owns 2,941 CRA International shares.
The filing notes that this sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025, which is designed to allow preset trades under specified conditions.
Positive
- None.
Negative
- None.
FAQ
What insider stock transaction did CRA International (CRAI) disclose?
CRA International disclosed that a director sold 110 shares of its common stock in a sale transaction on December 11, 2025 at a reported price of $198.12 per share.
How many CRAI shares does the director own after the reported sale?
After the reported transaction, the director directly beneficially owns 2,941 shares of CRA International common stock.
Was the CRAI insider sale made under a Rule 10b5-1 trading plan?
Yes. The filing explains that the transaction was effected under a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
What role does the reporting person hold at CRA International (CRAI)?
The reporting person is identified as a director of CRA International, with the 10% owner box not selected in the relationship section.
How is the ownership of the CRAI shares characterized after the transaction?
The remaining 2,941 CRA International shares are reported as being held with direct beneficial ownership.
What type of SEC form reports this CRAI insider transaction?
The insider sale by the CRA International director is reported on a Form 4, which discloses changes in beneficial ownership of company equity securities.